Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.
Child Psychiatry Hum Dev. 2011 Aug;42(4):424-41. doi: 10.1007/s10578-011-0227-4.
The primary aim of this paper is to examine the characteristics of a large sample of youth with OCD who are partial responders (i.e., still have clinically significant symptoms) to serotonin reuptake inhibitor (SRI) medication. The sample will be described with regard to: demographics, treatment history, OCD symptoms/severity, family history and parental psychopathology, comorbidity, and global and family functioning. The sample includes 124 youth with OCD ranging in age from 7 to 17 with a primary diagnosis of OCD and a partial response to an SRI medication. The youth are a predominantly older (age 12 and over), Caucasian, middle to upper income group who had received significant past treatment. Key findings include moderate to severe OCD symptoms, high ratings of global impairment, and significant comorbidity, despite partial response to an adequate medication trial. Considerations regarding generalizability of the sample and limitations of the study are discussed.
本文的主要目的是研究一组对选择性 5-羟色胺再摄取抑制剂(SSRIs)药物反应部分缓解(即仍存在临床显著症状)的大量青少年 OCD 患者的特征。将对该样本进行以下方面的描述:人口统计学特征、治疗史、OCD 症状/严重程度、家族史和父母精神病理学、共病和整体及家庭功能。该样本包括 124 名年龄在 7 至 17 岁之间、主要诊断为 OCD 且对 SSRIs 药物反应部分缓解的青少年 OCD 患者。这些青少年主要是年龄较大(12 岁及以上)、白种人、中高收入群体,他们接受过大量的既往治疗。主要发现包括中重度 OCD 症状、全球功能损害程度较高和显著的共病,尽管对充分的药物试验有部分反应。还讨论了样本的可推广性和研究的局限性。